Liesbeth J M BollenSara J. WhiteheadPhilip A. MockWanna LeelawiwatSuvanna AsavapiriyanontAmphan ChalermchockchareonkitNirun VanpraparTawee ChotpitayasunondhJanet M. McNichollJordan W. TapperoNathan ShafferRutt ChuachoowongThailand Ministry of Public HealthCenters for Disease Control and PreventionRajavithi HospitalMahidol University2018-07-122018-07-122008-06-19AIDS. Vol.22, No.10 (2008), 1169-117614735571026993702-s2.0-50949083036https://repository.li.mahidol.ac.th/handle/123456789/19321Objectives:: To evaluate the association between maternal herpes simplex virus type 2 seropositivity and genital herpes simplex virus type 2 shedding with perinatal HIV transmission. Study design:: Evaluation of women who participated in a 1996-1997 perinatal HIV transmission prevention trial in Thailand. Methods:: In this nonbreastfeeding population, women were randomized to zidovudine or placebo from 36 weeks gestation through delivery; maternal plasma and cervicovaginal HIV viral load and infant HIV status were determined for the original study. Stored maternal plasma and cervicovaginal samples were tested for herpes simplex virus type 2 antibodies by enzyme-linked immunoassay and for herpes simplex virus type 2 DNA by real-time PCR, respectively. Results:: Among 307 HIV-positive women with available samples, 228 (74.3%) were herpes simplex virus type 2 seropositive and 24 (7.8%) were shedding herpes simplex virus type 2. Herpes simplex virus type 2 seropositivity was associated with overall perinatal HIV transmission [adjusted odds ratio, 2.6; 95% confidence interval, 1.0-6.7)], and herpes simplex virus type 2 shedding was associated with intrapartum transmission (adjusted odds ratio, 2.9; 95% confidence interval, 1.0-8.5) independent of plasma and cervicovaginal HIV viral load, and zidovudine treatment. Median plasma HIV viral load was higher among herpes simplex virus type 2 shedders (4.2 vs. 4.1 log10copies/ml; P = 0.05), and more shedders had quantifiable levels of HIV in cervicovaginal samples, compared with women not shedding herpes simplex virus type 2 (62.5 vs. 34.3%; P = 0.005). Conclusion:: We found an increased risk of perinatal HIV transmission among herpes simplex virus type 2 seropositive women and an increased risk of intrapartum HIV transmission among women shedding herpes simplex virus type 2. These novel findings suggest that interventions to control herpes simplex virus type 2 infection could further reduce perinatal HIV transmission. © 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins.Mahidol UniversityImmunology and MicrobiologyMedicineArticleSCOPUS10.1097/QAD.0b013e3282fec42a